Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Argus Health
Queensland Health
Johnson and Johnson
Federal Trade Commission

Generated: April 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019404

« Back to Dashboard

NDA 019404 describes OCUFEN, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the OCUFEN profile page.

The generic ingredient in OCUFEN is flurbiprofen sodium. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.
Summary for 019404
Tradename:OCUFEN
Applicant:Allergan
Ingredient:flurbiprofen sodium
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019404
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404 NDA AUTHORIZED GENERIC Rebel Distributors Corp 42254-023 42254-023-25 1 BOTTLE, DROPPER in 1 CARTON (42254-023-25) > 2.5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.03%
Approval Date:Dec 31, 1986TE:ATRLD:Yes

Expired US Patents for NDA 019404

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404-001 Dec 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404-001 Dec 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Baxter
Deloitte
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.